Have a personal or library account? Click to login
Harmaline Tremor: Underlying Mechanisms in a Potential Animal Model of Essential Tremor Cover

Harmaline Tremor: Underlying Mechanisms in a Potential Animal Model of Essential Tremor

Open Access
|Sep 2012

References

  1. 1
    GuanYLouisEDZhengWToxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats.J Toxicol Environ Health A20016464566010.1080/15287390175324624111766171
  2. 2
    CallawayJCAiraksinenMMSalmelaKSSalaspuroMFormation of tetrahydroharman (1-methyl-1,2,3,4-tetrahydro-beta-carboline) by Helicobacter pylori in the presence of ethanol and tryptamine.Life Sci1996581817182110.1016/0024-3205(96)00165-88637407
  3. 3
    FekkesDBernardBFCappendijkSLNorharman and alcohol-dependency in male Wistar rats.Eur Neuropsychopharmacol20041436136610.1016/j.euroneuro.2003.10.00715336296
  4. 4
    BosinTRBorgSFaullKFHarman in rat brain, lung and human CSF: effect of alcohol consumption.Alcohol1988550551110.1016/0741-8329(88)90090-03245894
  5. 5
    SpijkermanRvan den EijndenRvan de MheenDBongersIFekkesDThe impact of smoking and drinking on plasma levels of norharman.Eur Neuropsychopharmacol200212617110.1016/S0924-977X(01)00143-211788242
  6. 6
    YuAMIdleJRKrauszKWKüpferAGonzalezFJContribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic β-carboline alkaloids harmaline and harmine.J Pharmacol Exp Ther200330531532210.1124/jpet.102.04705012649384
  7. 7
    MiksysSRaoYHoffmannEMashDCTyndaleRFRegional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics.J Neurochem2002821376138710.1046/j.1471-4159.2002.01069.x12354285
  8. 8
    MiksysSTyndaleRFNicotine induces brain CYP enzymes: relevance to Parkinson's disease.J Neural Transm Suppl20067017718010.1007/978-3-211-45295-0_2817017527
  9. 9
    GearhartDANeafseyEJCollinsMAPhenylethanolamine N-methyltransferase has β-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease.Neurochem Int20024061162010.1016/S0197-0186(01)00115-211900856
  10. 10
    HerraizTGuillénHGalisteoJN-methyltetrahydro-β-carboline analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic β-carbolinium cations by heme peroxidases.Biochem Biophys Res Commun200735611812310.1016/j.bbrc.2007.02.08917346675
  11. 11
    MatsubaraKGondaTSawadaHEndogenously occurring β-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease.J Neurochem19987072773510.1046/j.1471-4159.1998.70020727.x9453568
  12. 12
    HerraizTGuillénHAránVJIdleJRGonzalezFJComparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated β-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.Toxicol Appl Pharmacol200621638739810.1016/j.taap.2006.06.00316870220
  13. 13
    LouisEDBenito-LeónJBermejo-ParejaFNeurological Disorders in Central Spain (NEDICES) Study GroupPopulation-based prospective study of cigarette smoking and risk of incident essential tremor.Neurology2008701682168710.1212/01.wnl.0000311271.42596.3218458228
  14. 14
    McCannSJPondSMJamesKMLe CouteurDGThe association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis.J Neurol Sci1997153505310.1016/S0022-510X(97)00179-29455978
  15. 15
    LouisEDJiangWPellegrinoKMElevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor.Neurotoxicology20082929430010.1016/j.neuro.2007.12.00118242711
  16. 16
    LouisEDZhengWApplegateLShiLFactor-LitvakPBlood harmane concentrations and dietary protein consumption in essential tremor.Neurology20056539139610.1212/01.wnl.0000172352.88359.2d16087903
  17. 17
    ZetlerGSingbartlGSchlosserLCerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids.Pharmacology1972723724810.1159/0001362945077309
  18. 18
    LouisEDZhengWMaoXShunguDCBlood harmane is correlated with cerebellar metabolism in essential tremor: a pilot study.Neurology20076951552010.1212/01.wnl.0000266663.27398.9f17679670
  19. 19
    RibaJValleMUrbanoGYritiaMMorteABarbanojMJHuman pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.J Pharmacol Exp Ther2003306738310.1124/jpet.103.04988212660312
  20. 20
    PennesHHHochPHPsychotomimetics, clinical and theoretical considerations: harmine, Win-2299 and nalline.Am J Psychiatry195711388789213402982
  21. 21
    AhmedATaylorNRThe analysis of drug-induced tremor in mice.Br J Pharmacol Chemother19591435035413792135
  22. 22
    de MontignyCLamarreYRhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the cat.Brain Res197353819510.1016/0006-8993(73)90768-34697252
  23. 23
    PoirierLJSourkesTLBouvierGBoucherRCarabinSStriatal amines, experimental tremor and the effect of harmaline in the monkey.Brain196689375210.1093/brain/89.1.374956264
  24. 24
    MiwaHRodent models of tremor.Cerebellum20076667210.1080/1473422060101608017366267
  25. 25
    MiwaHHamaKKajimotoYKondoTEffects of zonisamide on experimental tremors in rats.Parkinsonism Relat Disord200814333610.1016/j.parkreldis.2007.05.00817587636
  26. 26
    WangGFowlerSCConcurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine.Psychopharmacology (Berl)200115827328010.1007/s00213010088211713617
  27. 27
    de Souza da FonsecaAPereiraFRSantosRValidation of a new computerized system for recording and analysing drug-induced tremor in rats.J Pharmacol Toxicol Methods20014613714310.1016/S1056-8719(02)00169-712183189
  28. 28
    MartinFCThu LeAHandforthAHarmaline-induced tremor as a potential preclinical screening method for essential tremor medications.Mov Disord20052029830510.1002/mds.2033115580562
  29. 29
    StanfordJAFowlerSCAt low doses, harmaline increases forelimb tremor in the rat.Neurosci Lett1998241414410.1016/S0304-3940(97)00974-99502211
  30. 30
    LutesJLordenJFBealesMOltmansGATolerance to the tremorogenic effects of harmaline: evidence for altered olivo-cerebellar function.Neuropharmacology19882784985510.1016/0028-3908(88)90102-52851115
  31. 31
    LordenJFStrattonSEMaysLEOltmansGAPurkinje cell activity in rats following chronic treatment with harmaline.Neuroscience19882746547210.1016/0306-4522(88)90281-33217001
  32. 32
    StrattonSELordenJFEffect of harmaline on cells of the inferior olive in the absence of tremor: differential response of genetically dystonic and harmaline-tolerant rats.Neuroscience19914154354910.1016/0306-4522(91)90347-Q1870702
  33. 33
    O'HearnEMolliverMEDegeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline.Neuroscience19935530331010.1016/0306-4522(93)90500-F8377927
  34. 34
    MiwaHKuboTSuzukiAKihiraTKondoTA species-specific difference in the effects of harmaline on the rodent olivocerebellar system.Brain Res200610689410110.1016/j.brainres.2005.11.03616405928
  35. 35
    LlinásRYaromYElectrophysiology of mammalian inferior olivary neurones in vitro. Different types of voltage-dependent ionic conductances.J Physiol19813155495676273544
  36. 36
    LlinásRYaromYProperties and distribution of ionic conductances generating electroresponsiveness of mammalian inferior olivary neurones in vitro.J Physiol19813155695847310722
  37. 37
    LlinásRYaromYOscillatory properties of guinea-pig inferior olivary neurones and their pharmacological modulation: an in vitro study.J Physiol19863761631823795074
  38. 38
    LangEJSugiharaILlinásRDifferential roles of apamin- and charybdotoxin-sensitive K+ conductances in the generation of inferior olive rhythmicity in vivo.J Neurosci199717282528389092604
  39. 39
    PlacantonakisDGSchwarzCWelshJPSerotonin suppresses subthreshold and suprathreshold oscillatory activity of rat inferior olivary neurones in vitro.J Physiol200052483385110.1111/j.1469-7793.2000.00833.x10790162
  40. 40
    PlacantonakisDWelshJTwo distinct oscillatory states determined by the NMDA receptor in rat inferior olive.J Physiol200153412314010.1111/j.1469-7793.2001.t01-1-00123.x11432997
  41. 41
    DegenJMeierCVan Der GiessenRSExpression pattern of lacZ reporter gene representing connexin36 in transgenic mice.J Comp Neurol200447351152510.1002/cne.2008515116387
  42. 42
    LeznikEMakarenkoVLlinásRElectrotonically mediated oscillatory patterns in neuronal ensembles: an in vitro voltage-dependent dye-imaging study in the inferior olive.J Neurosci2002222804281511923445
  43. 43
    SoteloCLlinásRBakerRStructural study of inferior olivary nucleus of the cat: morphological correlates of electrotonic coupling.J Neurophysiol1974375415594827021
  44. 44
    LeznikELlinásRRole of gap junctions in synchronized neuronal oscillations in the inferior olive.J Neurophysiol2005942447245610.1152/jn.00353.200515928056
  45. 45
    De ZeeuwCIVan AlphenAMHawkinsRKRuigrokTJClimbing fibre collaterals contact neurons in the cerebellar nuclei that provide a GABAergic feedback to the inferior olive.Neuroscience19978098198610.1016/S0306-4522(97)00249-29284054
  46. 46
    SasakiKBowerJMLlinásRMultiple purkinje cell recording in rodent cerebellar cortex.Eur J Neurosci1989157258610.1111/j.1460-9568.1989.tb00364.x12106116
  47. 47
    LangEJSugiharaILlinásRGABAergic modulation of complex spike activity by the cerebellar nucleoolivary pathway in rat.J Neurophysiol1996762552758836223
  48. 48
    LangEJGABAergic and glutamatergic modulation of spontaneous and motor-cortex-evoked complex spike activity.J Neurophysiol2002871993200811929918
  49. 49
    WelshJPLangEJSuglharaILlinásRDynamic organization of motor control within the olivocerebellar system.Nature199537445345710.1038/374453a07700354
  50. 50
    Van Der GiessenRSMaxeinerSFrenchPJWilleckeKDe ZeeuwCISpatiotemporal distribution of Connexin45 in the olivocerebellar system.J Comp Neurol200649517318410.1002/cne.2087316435305
  51. 51
    LongMADeansMRPaulDLConnorsBWRhythmicity without synchrony in the electrically uncoupled inferior olive.J Neurosci200222108981090512486184
  52. 52
    PlacantonakisDGBukovskyAAZengXHKiemHPWelshJPFundamental role of inferior olive connexin 36 in muscle coherence during tremor.Proc Natl Acad Sci USA20041017164716910.1073/pnas.040032210115103021
  53. 53
    PlacantonakisDGBukovskyAAAicherSAKiemHPWelshJPContinuous electrical oscillations emerge from a coupled network: a study of the inferior olive using lentiviral knockdown of connexin36.J Neurosci2006265008501610.1523/JNEUROSCI.0146-06.200616687492
  54. 54
    MarshallSPvan der GiessenRSde ZeeuwCILangEJAltered olivocerebellar activity patterns in the connexin36 knockout mouse.Cerebellum200728113
  55. 55
    BlenkinsopTALangEJBlock of inferior olive gap junctional coupling decreases Purkinje cell complex spike synchrony and rhythmicity.J Neurosci2006261739174810.1523/JNEUROSCI.3677-05.200616467522
  56. 56
    TeuneTMvan der BurgJde ZeeuwCIVoogdJRuigrokTJSingle Purkinje cell can innervate multiple classes of projection neurons in the cerebellar nuclei of the rat: a light microscopic and ultrastructural triple-tracer study in the rat.J Comp Neurol199839216417810.1002/(SICI)1096-9861(19980309)392:2<;164::AID-CNE2>3.0.CO;2-09512267
  57. 57
    MolineuxMLMcRoryJEMcKayBESpecific T-type calcium channel isoforms are associated with distinct burst phenotypes in deep cerebellar nuclear neurons.Proc Natl Acad Sci USA20061035555556010.1073/pnas.060126110316567615
  58. 58
    UusisaariMObataKKnöpfelTMorphological and electrophysiological properties of GABAergic and non-GABAergic cells in the deep cerebellar nuclei.J Neurophysiol20079790191110.1152/jn.00974.200617093116
  59. 59
    De MontignyCLamarreYEffects produced by local applications of harmaline in the inferior olive.Can J Physiol Pharmacol19755384584910.1139/y75-1161201490
  60. 60
    BatiniCBernardJFBuisseret-DelmasCConrath-VerrierMHorcholle-BossavitGHarmaline-induced tremor. II. Unit activity correlation in the interposito-rubral and oculomotor systems of cat.Exp Brain Res19814238339110.1007/BF002375037238678
  61. 61
    LlinásRVolkindRAThe olivo-cerebellar system: functional properties as revealed by harmaline-induced tremor.Exp Brain Res197318698710.1007/BF002365574746753
  62. 62
    BatiniCBuisseret-DelmasCConrath-VerrierMHarmaline-induced tremor. I. Regional metabolic activity as revealed by [14C]2-deoxyglucose in cat.Exp Brain Res19814237138210.1007/BF002375027238677
  63. 63
    BeitzAJSaxonDHarmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway.J Neurocytol200433497410.1023/B:NEUR.0000029648.81071.2015173632
  64. 64
    ParkYGParkHYLeeCJCaV3.1 is a tremor rhythm pacemaker in the inferior olive.Proc Natl Acad Sci USA2010107107311073610.1073/pnas.100299510720498062
  65. 65
    BernardJFBuisseret-DelmasCCompointCLaplanteSHarmaline induced tremor. III. A combined simple units, horseradish peroxidase, and 2-deoxyglucose study of the olivocerebellar system in the rat.Exp Brain Res19845712813710.1007/BF002311396519221
  66. 66
    Buisseret-DelmasCSagittal organization of the olivocerebellonuclear pathway in the rat. II. Connections with the nucleus interpositus.Neurosci Res1988549451210.1016/0168-0102(88)90039-93173810
  67. 67
    FredetteBJMugnainiEThe GABAergic cerebello-olivary projection in the rat.Anat Embryol (Berl)199118422524310.1007/BF016732581793166
  68. 68
    SimantovRSnyderSHOster-GraniteMLHarmaline-induced tremor in the rat: abolition by 3-acetylpyridine destruction of cerebellar climbing fibers.Brain Res197611414415110.1016/0006-8993(76)91016-7134757
  69. 69
    LeDouxMSLordenJFAbnormal spontaneous and harmaline-stimulated Purkinje cell activity in the awake genetically dystonic rat.Exp Brain Res200214545746710.1007/s00221-002-1127-412172657
  70. 70
    LordenJFOltmansGAMcKeonTWLutesJBealesMDecreased cerebellar 3',5'-cyclic guanosine monophosphate levels and insensitivity to harmaline in the genetically dystonic rat (dt).J Neurosci19855261826252995603
  71. 71
    MilnerTECadoretGLessardLSmithAMEMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive.J Neurophysiol199573256825777666163
  72. 72
    KraussJKWakhlooAKNobbeFTränkleRMundingerFSeegerWLesion of dentatothalamic pathways in severe post-traumatic tremor.Neurol Res1995174094168622792
  73. 73
    ElbleRJSchieberMHThachWTJrActivity of muscle spindles, motor cortex and cerebellar nuclei during action tremor.Brain Res198432333033410.1016/0006-8993(84)90308-16241010
  74. 74
    MonzéeJDrewTSmithAMEffects of muscimol inactivation of the cerebellar nuclei on precision grip.J Neurophysiol2004911240124910.1152/jn.01124.200214681335
  75. 75
    GembaHSasakiKYonedaYHashimotoSMizunoNTremor in the monkey with a cerebellar lesion.Exp Neurol19806917318210.1016/0014-4886(80)90152-16771153
  76. 76
    LlinásRMühlethalerMElectrophysiology of guinea-pig cerebellar nuclear cells in the in vitro brain stem-cerebellar preparation.J Physiol19884042412582855348
  77. 77
    LamarreYJoffroyAJDumontMDe MontignyCGrouFLundJPCentral mechanisms of tremor in some feline and primate models.Can J Neurol Sci19752227233809126
  78. 78
    BattistaAFNakataniSGoldsteinMAnagnosteBEffect of harmaline in monkeys with central nervous system lesions.Exp Neurol19702851352410.1016/0014-4886(70)90189-54990930
  79. 79
    VillablancaJRiobóFElectroencephalographic and behavioral effects of harmaline in intact cats and in cats with chronic mesencephalic transection.Psychopharmacologia19701730231310.1007/BF004042354331726
  80. 80
    BekarLLibionkaWTianGFAdenosine is crucial for deep brain stimulation-mediated attenuation of tremor.Nat Med200814758010.1038/nm169318157140
  81. 81
    DeecherDCTeitlerMSoderlundDMBornmannWGKuehneMEGlickSDMechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies.Brain Res199257124224710.1016/0006-8993(92)90661-R1377086
  82. 82
    HelsleySFiorellaDRabinRAWinterJCBehavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.Pharmacol Biochem Behav19985941942510.1016/S0091-3057(97)00451-69476990
  83. 83
    GrellaBDukatMYoungRInvestigation of hallucinogenic and related β-carbolines.Drug Alcohol Depend1998509910710.1016/S0376-8716(97)00163-49649961
  84. 84
    RobertsonHAHarmaline-induced tremor: the benzodiazepine receptor as a site of action.Eur J Pharmacol19806712913210.1016/0014-2999(80)90020-56252023
  85. 85
    SugiharaILangEJLlinásRSerotonin modulation of inferior olivary oscillations and synchronicity: a multiple-electrode study in the rat cerebellum.Eur J Neurosci1995752153410.1111/j.1460-9568.1995.tb00657.x7620604
  86. 86
    DuWAloyoVJHarveyJAHarmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brain.Brain Res1997770262910.1016/S0006-8993(97)00606-99372198
  87. 87
    MousahHJacqminPLesneMInteraction of carbolines and some GABA receptor ligands with the GABA and the benzodiazepine receptors.J Pharmacol1986176866913031382
  88. 88
    SchweriMCainMCookJPaulSSkolnickPBlockade of 3-carbomethoxy-β-carboline induced seizures by diazepam and the benzodiazepine antagonists, Ro 15-1788 and CGS8216.Pharmacol Biochem Behav19821745746010.1016/0091-3057(82)90304-56815667
  89. 89
    FrostholmAEvansJECummingsSLRotterAHarmaline-induced changes in gamma aminobutyric acidA receptor subunit mRNA expression in murine olivocerebellar nuclei.Brain Res Mol Brain Res20008520020810.1016/S0169-328X(00)00259-X11146122
  90. 90
    IshidaHSasaMTakaoriSIshidaHEffects of harmaline on membrane excitability and ATPase activity of the crayfish giant axon.Jpn J Pharmacol19813180180710.1254/jjp.31.8016118455
  91. 91
    SplettstoesserFBonnetUWiemannMBingmannDBüsselbergDModulation of voltage-gated channel currents by harmaline and harmane.Br J Pharmacol2005144525810.1038/sj.bjp.070602415644868
  92. 92
    SmartLCompetitive inhibition of sodium-dependent high affinity choline uptake by harmala alkaloids.Eur J Pharmacol19817526526910.1016/0014-2999(81)90553-77318912
  93. 93
    McCormickSJTunnicliffGInhibitors of synaptosomal gamma-hydroxybutyrate transport.Pharmacology19985712413110.1159/0000282339691232
  94. 94
    SchwarzMJHoughtonPJRoseSJennerPLeesADActivities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.Pharmacol Biochem Behav20037562763310.1016/S0091-3057(03)00129-112895680
  95. 95
    RobertsEWongESvennebyGDegenerPSodium-dependent binding of GABA to mouse brain particles.Brain Res197815261461910.1016/0006-8993(78)91119-880248
  96. 96
    ReidMSHsuKJrSouzaKHBroderickPABergerSPNeuropharmacological characterization of local ibogaine effects on dopamine release.J Neural Transm199610396798510.1007/BF012917879013390
  97. 97
    PimpinellaGPalmeryMInteraction of β-carbolines with central dopaminergic transmission in mice: structure-activity relationships.Neurosci Lett199518912112410.1016/0304-3940(95)11469-D7609916
  98. 98
    CummingPVincentSRInhibition of histamine-N-methyltransferase (HNMT) by fragments of 9-amino-1,2,3,4-tetrahydroacridine (tacrine) and by β-carbolines.Biochem Pharmacol19924498999210.1016/0006-2952(92)90133-41530666
  99. 99
    AiraksinenMMLecklinASaanoVTuomistoLGyntherJTremorigenic effect and inhibition of tryptamine and serotonin receptor binding by β-carbolines.Pharmacol Toxicol1987605810.1111/j.1600-0773.1987.tb01711.x3562389
  100. 100
    MirallesAEstebanSSastre-CollAMorantaDAsensioVJGarcia-SevillaJAHigh--affinity binding of β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.Eur J Pharmacol200551823424210.1016/j.ejphar.2005.06.02316061219
  101. 101
    WiklundLSjölundBBjörklundAMorphological and functional studies on the serotoninergic innervation of the inferior olive.J Physiol (Paris)1981771831866169826
  102. 102
    SjölundBBjörklundAWiklundLThe indolaminergic innervation of the inferior olive. 2. Relation to harmaline induced tremor.Brain Res1977131233710.1016/0006-8993(77)90026-9884545
  103. 103
    CostallBKellyDMNaylorRJThe importance of 5-hydroxytryptamine for the induction of harmine tremor and its antagonism by dopaminergic agonists assessed by lesions of the midbrain raphe nuclei.Eur J Pharmacol19763510911910.1016/0014-2999(76)90305-81253813
  104. 104
    WelshJPChangBMenakerMEAicherSARemoval of the inferior olive abolishes myoclonic seizures associated with a loss of olivary serotonin.Neuroscience19988287989710.1016/S0306-4522(97)00297-29483543
  105. 105
    MehtaHSaravananKSMohanakumarKPSerotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice.Behav Brain Res2003145313610.1016/S0166-4328(03)00094-914529803
  106. 106
    ArshaduddinMKadasahSAl DeebSAl MoutaeryKTariqMExacerbation of harmaline-induced tremor by imipramine.Pharmacol Biochem Behav20058191410.1016/j.pbb.2005.01.01415894058
  107. 107
    ArshaduddinMAl KadasahSBiaryNAl DeebSAl MoutaeryKTariqMCitalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats.Behav Brain Res2004153152010.1016/j.bbr.2003.10.03515219702
  108. 108
    YamazakiMIkedaYIshikawaMInagakiCTanakaCInhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor.Nippon Yakurigaku Zasshi19767236336910.1254/fpj.72.363986992
  109. 109
    YamazakiMTanakaCTakaoriSSignificance of central noradrenergic system on harmaline induced tremor.Pharmacol Biochem Behav19791042142710.1016/0091-3057(79)90207-7450952
  110. 110
    KolasiewiczWKuterKNowakPPastuszkaAOssowskaKLesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.Cerebellum20111026728010.1007/s12311-011-0250-921279489
  111. 111
    CoxBPotkonjakDAn investigation of the tremorgenic actions of harmine in the rat.Eur J Pharmacol197116394510.1016/0014-2999(71)90054-94945584
  112. 112
    KulkarniSKKaulPNModification by levo-propranolol of tremors induced by harmine in mice.Experientia1979351627162810.1007/BF01953232520477
  113. 113
    PaulVInvolvement of β2-adrenoceptor blockade and 5-hydroxytryptamine mechanism in inhibition of harmaline-induced tremors in rats.Eur J Pharmacol198612211111510.1016/0014-2999(86)90165-22869961
  114. 114
    NiespodzianyIKlitgaardHMargineanuDEffects of brivaracetam (UCB 34714) on harmaline-induced electrophysiological changes in rat inferior olivary neurons.Soc Neurosci Abst20059711
  115. 115
    WoodPLRichardJWPilapilCNairNPAntagonists of excitatory amino acids and cyclic guanosine monophosphate in cerebellum.Neuropharmacology1982211235123810.1016/0028-3908(82)90126-56130488
  116. 116
    KollerWCIneffectiveness of phenoxybenzamine in essential tremor.J Neurol Neurosurg Psychiatry19864922210.1136/jnnp.49.2.222-a3950649
  117. 117
    EblenFLöschmannPAWüllnerUTurskiLKlockgetherTEffects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.Eur J Pharmacol199629991610.1016/0014-2999(95)00795-48901001
  118. 118
    PatersonNEMalekianiSAForemanMMOlivierBHananiaTPharmacological characterization of harmaline-induced tremor activity in mice.Eur J Pharmacol2009616738010.1016/j.ejphar.2009.05.03119497322
  119. 119
    DuWHarveyJAHarmaline-induced tremor and impairment of learning are both blocked by dizocilpine in the rabbit.Brain Res199774518318810.1016/S0006-8993(96)01148-19037408
  120. 120
    IseriPKKarsonAGulluKMThe effect of memantine in harmaline-induced tremor and neurodegeneration.Neuropharmacology20116171572310.1016/j.neuropharm.2011.05.01521640732
  121. 121
    HandforthABordelonYFruchtSJQuesadaAA pilot efficacy and tolerability trial of memantine for essential tremor.Clin Neuropharmacol20103322322610.1097/WNF.0b013e3181ebd10920838216
  122. 122
    MignaniSBohmeGABirrauxG9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic acid (RPR117824): selective anticonvulsive and neuroprotective AMPA antagonist.Bioorg Med Chem2002101627163710.1016/S0968-0896(01)00431-X11886824
  123. 123
    KolasiewiczWKuterKWardasJOssowskaKRole of the metabotropic glutamate receptor subtype 1 in the harmaline-induced tremor in rats.J Neural Transm20091161059106310.1007/s00702-009-0254-519551466
  124. 124
    ShinozakiHHirateKIshidaMFurther studies on quantification of drug-induced tremor in mice: effects of antitremorgenic agents on tremor frequency.Exp Neurol19858830331510.1016/0014-4886(85)90193-13987859
  125. 125
    TariqMArshaduddinMBiaryNAl MoutaeryKAl DeebSBaclofen attenuates harmaline induced tremors in rats.Neurosci Lett2001312798210.1016/S0304-3940(01)02166-811595339
  126. 126
    MeertTFPharmacological evaluation of alcohol withdrawal-induced inhibition of exploratory behaviour and supersensitivity to harmine-induced tremor.Alcohol Alcohol199429911027911667
  127. 127
    RappaportMSGentryRTSchneiderDRDoleVPEthanol effects on harmaline--induced tremor and increase of cerebellar cyclic GMP.Life Sci198434495610.1016/0024-3205(84)90329-16319933
  128. 128
    RogersJMadambaSGStauntonDASigginsGREthanol increases single unit activity in the inferior olivary nucleus.Brain Res 1986 22385253262
  129. 129
    GarbourgYWelshJPSystemic ethanol induces inferior olive synchrony and oscillation in vivo.Soc Neurosci Abst200074316
  130. 130
    De RyckMMatagneAKendaBMichelPKlitgaardHContrasting effects of UCB 34714 and drugs for essential tremor on harmaline-induced elicited versus spontaneous tremor and sedation in rats.Mov Disord200419S443
  131. 131
    HandforthAMartinFCKangGAVanekZZonisamide for essential tremor: an evaluator-blinded study.Mov Disord20092443744010.1002/mds.2241819117357
  132. 132
    StöhrTLekieffreDFreitagJLacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats.Eur J Pharmacol200858911411610.1016/j.ejphar.2008.06.03818585381
  133. 133
    GironellAPagonabarragaJPascual-SedanoBKulisevskyJLacosamide, another therapeutic failure in essential tremor: an open-label trial.Mov Disord20112618318410.1002/mds.2329620925072
  134. 134
    ElbleRJBiondiDMAscherSWiegandFHulihanJCarisbamate in essential tremor: brief report of a proof of concept study.Mov Disord20102563463810.1002/mds.2287220201005
  135. 135
    MartinFCHandforthACarbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor.Mov Disord2006211641164910.1002/mds.2094016773639
  136. 136
    ZappalàAParentiRLa DeliaFCicirataVCicirataFExpression of connexin57 in mouse development and in harmaline-tremor model.Neuroscience201017111110.1016/j.neuroscience.2010.09.01020849935
  137. 137
    SintonCMKrosserBIWaltonKDLlinásRRThe effectiveness of different isomers of octanol as blockers of harmaline-induced tremor.Pflugers Arch1989414313610.1007/BF005856232542888
  138. 138
    HandforthAHomanicsGECoveyDFT-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.Neuropharmacology20105938038710.1016/j.neuropharm.2010.05.01220547167
  139. 139
    QuesadaABuiPHHomanicsGEHankinsonOHandforthAComparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor.Eur J Pharmacol2011659303610.1016/j.ejphar.2011.01.004
  140. 140
    BuiPHQuesadaAHandforthAHankinsonOThe mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil.Drug Metab Dispos2008361291129910.1124/dmd.107.02011518411403
  141. 141
    Al-DeebSAl-MoutaeryKArshaduddinMBiaryNTariqMEffect of acute caffeine on severity of harmaline induced tremor in rats.Neurosci Lett200232521621810.1016/S0304-3940(02)00042-312044659
  142. 142
    BiaryNArshaduddinMAl DeebSAl MoutaeryKTariqMEffect of lidocaine on harmaline-induced tremors in the rat.Pharmacol Biochem Behav20006511712110.1016/S0091-3057(99)00175-610638644
  143. 143
    BertiFFanoMFolcoGCLongiaveDOminiCInhibition of harmaline induced tremors by 16 (S)-16-methyl PGE2 in different mammalian species: a correlation with central cyclic nucleotides and prostaglandins.Prostaglandins19781586787410.1016/0090-6980(78)90153-3704910
  144. 144
    ShutoHKataokaYKanayaAMatsunagaKSueyasuMOishiREnhancement of serotonergic neural activity contributes to cyclosporine-induced tremors in mice.Eur J Pharmacol1998341333710.1016/S0014-2999(97)01441-69489853
  145. 145
    ZoethoutRWIannoneRBloemBRThe effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol.J Psychopharmacol20122629230210.1177/026988111139868521335358
  146. 146
    ScarmeasNLouisEDMediterranean diet and essential tremor. A case-control study.Neuroepidemiology20072917017710.1159/00011157918043001
  147. 147
    LouisEDFaustPLVonsattelJPNeuropathological changes in essential tremor: 33 cases compared with 21 controls.Brain20071303297330710.1093/brain/awm26618025031
  148. 148
    KronenbuergerMGerwigMBrolBBlockFTimmannDEyeblink conditioning is impaired in subjects with essential tremor.Brain20071301538155110.1093/brain/awm08117468116
  149. 149
    HallettMDubinskyRMGlucose metabolism in the brain of patients with essential tremor.J Neurol Sci1993114454810.1016/0022-510X(93)90047-38433096
  150. 150
    WillsAJJenkinsIHThompsonPDFindleyLJBrooksDJRed nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study.Ann Neurol19943663664210.1002/ana.4103604137944296
  151. 151
    BoeckerHWillsAJCeballos-BaumannAThe effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study.Ann Neurol19963965065810.1002/ana.4103905158619551
  152. 152
    ShillHABusharaKOMariZReichMHallettMOpen-label dose-escalation study of oral 1-octanol in patients with essential tremor.Neurology2004622320232210.1212/WNL.62.12.232015210907
  153. 153
    NahabFBWittevrongelLIppolitoDAn open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor.Neurotherapeutics2011875376210.1007/s13311-011-0045-121594724
  154. 154
    HandforthAMartinFCPilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.Mov Disord2004191215122110.1002/mds.2014715390011
  155. 155
    FruchtSJHoughtonWCBordelonYGreenePELouisEDA single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor.Neurology2005651967196910.1212/01.wnl.0000188670.38576.bd16382538
DOI: https://doi.org/10.5334/tohm.108 | Journal eISSN: 2160-8288
Language: English
Submitted on: Feb 13, 2012
Accepted on: Mar 24, 2012
Published on: Sep 12, 2012
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2012 Adrian Handforth, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.